🇺🇸 FDA
Pipeline program

Administration of UI087

KUP-UI087-101

Phase 1 small_molecule active

Quick answer

Administration of UI087 for Diabetes Mellitus (Type 2) is a Phase 1 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Diabetes Mellitus (Type 2)
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials